Effect of levothyroxine on live birth rate in euthyroid women with recurrent miscarriage and TPO antibodies (T4-LIFE study)

Contemporary Clinical Trials

Volumn 44, Issue , 2015, Pages 134-138

  Vissenberg, R ^a   van Dijk, M M ^a   Fliers, E ^a   van der Post, J A M ^a   van Wely, M ^a   Bloemenkamp, K W M ^b   Hoek, A ^c   Kuchenbecker, W K ^d   Verhoeve, H R ^e   Scheepers, H C J ^f   Rombout de Weerd, S ^g   Koks, C ^h   Zwart, J J ⁱ   Broekmans, F ^j   Verpoest, W ^k   Christiansen, O B ^l   Post, M ^m   Papatsonis, D N M ⁿ   Verberg, M F G ^o   Sikkema, J ^p   Mol, B W ^q   Bisschop, P H ^a   Goddijn, M ^a   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ISALA HOSPITAL   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^h MÁXIMA MEDICAL CENTER   (Netherlands)

ⁱ DEVENTER HOSPITAL   (Netherlands)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^l Mental Health Center Glostrup   (Denmark)

^m MEDICAL CENTER LEEUWARDEN   (Netherlands)

ⁿ AMPHIA HOSPITAL   (Netherlands)

^o MEDISCH SPECTRUM TWENTE   (Netherlands)

^p TWENTEBORG HOSPITAL   (Netherlands)

^q UNIVERSITY OF ADELAIDE   (Australia)

more..

Author keywords

Levothyroxine; Live birth rate; Preterm birth; Recurrent miscarriage; Thyroid autoimmunity; TPO antibodies

Indexed keywords

LEVOTHYROXINE; PLACEBO; THYROID PEROXIDASE ANTIBODY;

ARTICLE; BIRTH RATE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EUTHYROIDISM; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; INTENTION TO TREAT ANALYSIS; LIVE BIRTH; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RECURRENT MISCARRIAGE; SPONTANEOUS ABORTION; SURVIVAL RATE; SURVIVAL TIME; TIME TO PREGNANCY;

EID: 84939603179     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.08.005     Document Type: Article

References (29)

1. Rai R., Regan L. Recurrent miscarriage. Lancet 2006, 368(9535):601-611.
2. Kaandorp S.P., Goddijn M., van der Post J.A., Hutten B.A., Verhoeve H.R., Hamulyak K., et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N. Engl. J. Med. 2010, 362(17):1586-1596.
3. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil. Steril. 2012, 98(5):1103-1111.
4. Goddijn M., van den Boogaard E., Steepers E.A., Erwich J.J., Macklon N.S., Land J.A., et al. The guideline 'recurrent miscarriage' (first revision) of the Dutch Society for Obstetrics and Gynaecology. Ned. Tijdschr. Geneeskd. 2008, 152(30):1665-1670.
5. Farquharson R.G., Jauniaux E., Exalto N. Updated and revised nomenclature for description of early pregnancy events. Hum. Reprod. 2005, 20(11):3008-3011.
6. Jaslow C.R., Carney J.L., Kutteh W.H. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil. Steril. 2010, 93(4):1234-1243.
7. van den Boogaard E., Kaandorp S.P., Franssen M.T., Mol B.W., Leschot N.J., Wouters C.H., et al. Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status?. Hum. Reprod. 2010, 25(6):1411-1414.
8. Kolte A.M., Bernardi L.A., Christiansen O.B., Quenby S., Farquharson R.G., Goddijn M., et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum. Reprod. 2015, 30(3):495-498.
9. Li T.C., Makris M., Tomsu M., Tuckerman E., Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum. Reprod. Update 2002, 8(5):463-481.
10. van den Boogaard E., Vissenberg R., Land J.A., van W.M., van der Post J.A., Goddijn M., et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum. Reprod. 2011, 17(5):605-619. (Update).
11. Krassas G.E., Poppe K., Glinoer D. Thyroid function and human reproductive health. Endocr. Rev. 2010, 31(5):702-755.
12. Iravani A.T., Saeedi M.M., Pakravesh J., Hamidi S., Abbasi M. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr. Pract. 2008, 14(4):458-464.
13. Roberts J., Jenkins C., Wilson R., Pearson C., Franklin I.A., MacLean M.A., et al. Recurrent miscarriage is associated with increased numbers of CD5/20 positive lymphocytes and an increased incidence of thyroid antibodies. Eur. J. Endocrinol. 1996, 134(1):84-86.
14. Glinoer D., Riahi M., Grun J.P., Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J. Clin. Endocrinol. Metab. 1994, 79(1):197-204.
15. Bussen S., Steck T. Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions. Hum. Reprod. 1995, 10(11):2938-2940.
16. Rushworth F.H., Backos M., Rai R., Chilcott I.T., Baxter N., Regan L. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum. Reprod. 2000, 15(7):1637-1639.
17. The Investigation and Treatment of Couples with Recurrent First-trimester and Second-trimester Miscarriage. Green-top Guideline No. 17; RCOG 2015.
18. Jauniaux E., Farquharson R.G., Christiansen O.B., Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum. Reprod. 2006, 21(9):2216-2222.
19. Vissenberg R., van den Boogaard E., van Wely M., van der Post J.A., Fliers E., Bisschop P.H., et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum. Reprod. Update 2012, 18(4):360-373.
20. De G.L., Abalovich M., Alexander E.K., Amino N., Barbour L., Cobin R.H., et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2012, 97(8):2543-2565.
21. Stagnaro-Green A., Abalovich M., Alexander E., Azizi F., Mestman J., Negro R., et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011, 21(10):1081-1125.
22. Negro R., Mangieri T., Coppola L., Presicce G., Casavola E.C., Gismondi R., et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum. Reprod. 2005, 20(6):1529-1533.
23. Negro R., Formoso G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J. Clin. Endocrinol. Metab. 2006, 91(7):2587-2591.
24. Abalovich M., Amino N., Barbour L.A., Cobin R.H., De Groot L.J., Glinoer D., et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2007, 92(8 Suppl):S1-S47.
25. Vaidya B., Hubalewska-Dydejczyk A., Laurberg P., Negro R., Vermiglio F., Poppe K. Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur. J. Endocrinol. 2012, 166(1):49-54.
26. Thangaratinam S., Tan A., Knox E., Kilby M.D., Franklyn J., Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011, 342:d2616.
27. McCarthy F., Moss-Morris R., Khashan A., North R., Baker P., Dekker G., et al. Previous Pregnancy Loss has an Adverse Impact on Distress and Behaviour in Subsequent Pregnancy 2015, BJOG.
28. McCarthy F.P., Khashan A.S., North R.A., Rahma M.B., Walker J.J., Baker P.N., et al. Pregnancy loss managed by cervical dilatation and curettage increases the risk of spontaneous preterm birth. Hum. Reprod. 2013, 28(12):3197-3206.
29. Iams J. Prevention of preterm birth. N. Engl. J. Med. 1998, 338(1):54-56.